CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-25 | MORRISON DENISE M Director | Grant or award | +1,363 | 5,206 | ||
| 2021-05-21 | Gregg Vicky B Director | Grant or award | +1,363 | 15,400 | ||
| 2021-05-18 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Shares withheld for taxes | −5 | $136.60 | $683 | 26,859 |
| 2021-05-07 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Sale | −8,536 | $139.96 | $1.2M | 68,729 |
| 2021-05-05 | PREVOZNIK MICHAEL E SVP & General Counsel | Exercise or conversion | +44,939 | $71.17 | $3.2M | 85,091 |
| 2021-05-05 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −44,939 | $137.00 | $6.2M | 40,152 |
| 2021-05-05 | PREVOZNIK MICHAEL E SVP & General Counsel | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −44,939 | $71.17 | $3.2M | 0 |
| 2021-04-01 | RING TIMOTHY M Director | Grant or award · Phantom Stock Units | +325.79 | $128.47 | $42K | 10,638.79 |
| 2021-03-10 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −5,574 | $120.47 | $671K | 40,152 |
| 2021-03-09 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Grant or award | +58,368 | $115.42 | $6.7M | 310,314 |
| 2021-03-09 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Shares withheld for taxes | −25,887 | $115.42 | $3.0M | 284,427 |
| 2021-03-09 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award | +9,791 | $115.42 | $1.1M | 49,943 |
| 2021-03-09 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes | −4,217 | $115.42 | $487K | 45,726 |
| 2021-03-09 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Grant or award | +1,884 | $115.42 | $217K | 27,485 |
| 2021-03-09 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Shares withheld for taxes | −684 | $115.42 | $79K | 26,802 |
| 2021-03-09 | GUINAN MARK Executive Vice President & CFO | Grant or award | +17,322 | $115.42 | $2.0M | 95,195 |
| 2021-03-09 | GUINAN MARK Executive Vice President & CFO | Shares withheld for taxes | −6,403 | $115.42 | $739K | 88,792 |
| 2021-03-09 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Grant or award | +11,299 | $115.42 | $1.3M | 82,331 |
| 2021-03-09 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Shares withheld for taxes | −5,066 | $115.42 | $585K | 77,265 |
| 2021-03-09 | Davis J. E. EVP, General Diagnostics | Grant or award | +16,570 | $115.42 | $1.9M | 58,265 |
Page 36 of 42 · 826 trades